Skip to main content

Advertisement

Table 1 Demographic and baseline data a

From: Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial

  N=17
Age (years), Mean (SD) 31.8 (10.9)
Sex (female) 9 (52.9%)
Brain  
 Cortical Tubers 14 (82.4%)
 Seizures 11 (64.7%)
 Cognitive Impairment 11 (64.7%)
 Astrocytomab 3 (17.7%)
Skin  
 Facial angiofibroma 17 (100.0%)
 Hipomelanotic macules 15 (88.2%)
 Ungual fibroma 6 (35.3%)
 Shagreen patch 9 (52.9%)
Renal  
 Angiomyolipomas 5 1 ( 5.9%)
          10 1 ( 5.9%)
          Multiple 15 (88.2%)
 Vascular embolization 3 (17.7%)
 Nephrectomy 3 (17.64%)
  1. aDescriptive statistics are frequencies and percentages or otherwise specified.
  2. bAstrocytomas had been removed and were not present at the moment of trial initiation.